11-Hydroxylation in the biosynthesis of endogenous ouabain: Multiple implications

Annals of the New York Academy of Sciences

Volumn 986, Issue , 2003, Pages 685-693

  Hamlyn, John M ^a   Laredo, James ^a   Shah, Jui R ^a   Lu, Zhuo Ren ^a   Hamilton, Bruce P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Adrenal; Metabolism; Metyrapone

Indexed keywords

ENZYME INHIBITOR; HYDROXYL GROUP; OUABAIN; PREGNENOLONE; PROGESTERONE; STEROID 11BETA MONOOXYGENASE;

ADRENAL CORTEX CELL; ADRENAL GLAND; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CELL CULTURE; CONFERENCE PAPER; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; ISOMER; NONHUMAN; PROTEIN ISOLATION; STEROID HYDROXYLATION;

BOVINAE; DIGITALIS; MAMMALIA; STROPHANTHUS GRATUS;

EID: 0038239693     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07283.x     Document Type: Conference Paper

References (45)

1. REICHSTEIN, T. 1967. Cardenolid- und pregnanglykoside. Die Naturwissenschaften 3: 53-76.
2. HORIGER, N. et al. 1970. Cardenolide hydrogen suberates and other bufadienolide hydrogen suberates in Ch'an Su. Helv. Chim. Acta 53: 1993-2002.
3. HAMLYN, J.M. et al. 1989. Digitalis-like activity in human plasma: purification, affinity, and mechanism. J. Biol. Chem. 264: 7395-7404.
4. HAMLYN, J.M. et al. 1991. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 88: 6259-6263.
5. MATHEWS, W.R. et al. 1991. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 17: 930-935.
6. GOTO, A. et al. 1992. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol. Rev. 44: 377-399.
7. HAMLYN, J.M. et al. 1996. Endogenous ouabain, sodium balance, and blood pressure: a review and a hypothesis. J. Hypertens. 14: 151-167.
8. EL-MASRI, M.A. et al. 2002. Human adrenal cells in culture produce both ouabain-like (OLF) and dihydroouabain-like (Dh-OLF) factors. Clin. Chem. 48: 1720-1730.
9. SCHONER, W. 2002. Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 269: 2440-2448.
10. KOMIYAMA, Y. et al. 2001. Identification of endogenous ouabain in culture supernatant of PC12 cells. J. Hypertens. 19: 229-236.
11. SCHNEIDER, R. et al. 1998. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 273: 784-792.
12. KAWAMURA, A. et al. 1999. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. USA 96: 6654-6659.
13. HARRIS, D.W. et al. 1991. Development of an immunoassay for endogenous digitalislike factor. Hypertension 17: 936-943.
14. FERRANDI, M. et al. 1995. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats. J. Hypertens. 13: 1571-1574.
15. LUDENS, J.H. et al. 1992. Rat adrenal cortex is a source of a circulating ouabainlike compound. Hypertension 19: 721-724.
16. BOULANGER, B.R. et al. 1993. Ouabain is secreted by the adrenal gland in awake dogs. Am. J. Physiol. 264: E413-E419.
17. LAREDO, J. et al. 1994. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135: 794-797.
18. MANUNTA, P. et al. 1994. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J. Hypertens. 12: 549-560.
19. MANUNTA, P. et al. 2001. Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 38: 198-203.
20. GOTTLIEB, S.S. et al. 1992. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86: 420-425.
21. PIERDOMENICO, S.D. et al. 2001. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am. J. Hypertens. 14: 44-50.
22. MANUNTA, P. et al. 1999. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 34: 450-456.
23. AILERU, A.A. et al. 2001. Synaptic plasticity in sympathetic ganglia from acquired and inherited forms of ouabain-dependent hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R635-R644.
24. ZHANG, J. & F.H. LEENEN. 2001. AT1 receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am. J. Physiol. Heart Circ. Physiol. 280: H1318-H1323.
25. HUANG, B.S. et al. 2000. Chronic blockade of brain "ouabain" prevents sympathetic hyper-reactivity and impairment of acute baroreflex resetting in rats with congestive heart failure. Can. J. Physiol. Pharmacol. 78: 45-53.
26. LI, S. et al. 1998. Bovine adrenals and hypothalamus are a major source of proscillaridin A- and ouabain-immunoreactivities. Life Sci. 62: 1023-1033.
27. 3H]ouabain from the cell surface into the lysosomal compartment of HeLa cells. J. Cell. Physiol. 110: 84-92.
28. HINSON, J.P. et al. 1998. Release of ouabain-like compound (OLC) from the intact perfused rat adrenal gland. Endocrinol. Res. 24: 721-724.
29. DE ANGELIS, C. & G.T. HAUPERT, JR. 1998. Hypoxia triggers release of an endogenous inhibitor of Na(+)-K(+)-ATPase from midbrain and adrenal. Am. J. Physiol. 274: F182-F188.
30. BECK, M. et al. 1996. Production of ouabain by rat adrenocortical cells. Endocrinol. Res. 22: 845-849.
31. SHAH, J.R. et al. 1998. Different signaling pathways mediate stimulated secretion of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 31: 463-468.
32. LAREDO, J. et al. 2000. Alpha-1 adrenergic receptors stimulate secretion of endogenous ouabain from human and bovine adrenocortical cells. In Na/K-ATPase and Related ATPases: 671-679. Elsevier Science. New York.
33. PERRIN, A. et al. 1997. Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol. Cell. Endocrinol. 126: 7-15.
34. HAMLYN, J.M. et al. 1998. Observations on the nature, biosynthesis, secretion, and significance of endogenous ouabain. Clin. Exp. Hypertens. 20: 523-533.
35. LU, Z-R. et al. 1998. Biosynthesis of endogenous ouabain from pregnenolone and progesterone in bovine adrenal cortical cells. Hypertension 32: P131.
36. LICHTSTEIN, D. et al. 1998. Biosynthesis of digitalis-like compounds in rat adrenal cells: hydroxycholesterol as possible precursor. Life Sci. 62: 2109-2116.
37. DMITRIEVA, R.I. et al. 2000. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension 36: 442-448.
38. CASPI, E. & D.O. LEWIS. 1967. Progesterone: its possible role in the biosynthesis of cardenolides in Digitalis lanata. Science 156: 519-520.
39. CASPI, E. et al. 1968. The role of deoxycorticosterone in the biosynthesis of cardenolides in Digitalis lanata. Biochem. J. 108: 499-503.
40. LUDENS, J.H. et al. 1991. Purification of an endogenous digitalislike factor from human plasma for structural analysis. Hypertension 17: 923-929.
41. HAMLYN, J.M. & P. MANUNTA. 1992. Ouabain, digitalis-like factors, and hypertension. J. Hypertens. Suppl. 10: S99-S111.
42. SANDOR, T. & D.R. IDLER. 1972. Steroid methodology. In Steroids in Nonmammalian Vertebrates: 6-36. Academic Press. New York.
43. TYMIAK, A.A. et al. 1993. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc. Natl. Acad. Sci. USA 90: 8189-8193.
44. ZHAO, N. et al. 1995. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 34: 9893-9896.
45. KAWAMURA, A. et al. 2001. Biological implication of conformational flexibility in ouabain: observations with two ouabain phosphate isomers. Biochemistry 40: 5835-5844.